Brief: Intra-Cellular Therapies Q2 Net Income USD -42.8 Million
03/08/2023 12:30
Aug 03 (Reuters) - Intra-Cellular Therapies Q2 product revenue USD 110.8 million. * Outlook FY Product Revenue USD 445-465 Million
Recent news on Intra-Cellular Therapies
See all newsBrief: Intra-Cellular Therapies stockholder filed lawsuit against co, board in NY Supreme Court
Intra-Cellular Therapies Inc reports results for the quarter ended December 31 - Earnings Summary
U.S. RESEARCH ROUNDUP-Apple, Caterpillar, Visa
Street View: New drug launches, ITCI deal to boost J&J's growth
J&J beats quarterly sales and profit estimates on cancer drug sales (updated)